Engineering the Signal Resolution of a Paper-Based Cell-Free Glutamine Biosensor with Genetic Engineering, Metabolic Engineering, and Process Optimization

Tyler J. Free,Joseph P. Talley,Chad D. Hyer,Catherine J. Miller,Joel S. Griffitts,Bradley C. Bundy

DOI: https://doi.org/10.3390/s24103073

IF: 3.9

2024-05-13

Sensors

Abstract:Specialized cancer treatments have the potential to exploit glutamine dependence to increase patient survival rates. Glutamine diagnostics capable of tracking a patient's response to treatment would enable a personalized treatment dosage to optimize the tradeoff between treatment success and dangerous side effects. Current clinical glutamine testing requires sophisticated and expensive lab-based tests, which are not broadly available on a frequent, individualized basis. To address the need for a low-cost, portable glutamine diagnostic, this work engineers a cell-free glutamine biosensor to overcome assay background and signal-to-noise limitations evident in previously reported studies. The findings from this work culminate in the development of a shelf-stable, paper-based, colorimetric glutamine test with a high signal strength and a high signal-to-background ratio for dramatically improved signal resolution. While the engineered glutamine test is important progress towards improving the management of cancer and other health conditions, this work also expands the assay development field of the promising cell-free biosensing platform, which can facilitate the low-cost detection of a broad variety of target molecules with high clinical value.

engineering, electrical & electronic,instruments & instrumentation,chemistry, analytical

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a low - cost, portable, and highly sensitive glutamine biosensor to overcome the problems of background signal interference and low signal - to - noise ratio in existing glutamine detection methods. Specifically, through genetic engineering, metabolic engineering, and process optimization methods, the paper has improved the signal resolution of the paper - based cell - free glutamine biosensor. This improvement aims to increase the signal strength and signal - to - background ratio of the sensor, thereby significantly improving the signal resolution, enabling the biosensor to more accurately detect glutamine levels in clinical applications, especially providing support for personalized dose adjustment in cancer treatment. In addition, this work has also expanded the application range of cell - free biosensing platforms in low - cost detection of target molecules with high clinical value.